A citation-based method for searching scientific literature

. Diabetes Care 2018
Times Cited: 988







List of co-cited articles
266 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
7

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
7

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
6

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
5

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
5

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
5

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
5


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
5

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
5

Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016.
Pooyan Kazemian, Fatma M Shebl, Nicole McCann, Rochelle P Walensky, Deborah J Wexler. JAMA Intern Med 2019
87
5

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review.
Thomas R Einarson, Annabel Acs, Craig Ludwig, Ulrik H Panton. Value Health 2018
90
5

Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.
Moien Abdul Basith Khan, Muhammad Jawad Hashim, Jeffrey Kwan King, Romona Devi Govender, Halla Mustafa, Juma Al Kaabi. J Epidemiol Glob Health 2020
289
5

Social Determinants of Health and Diabetes: A Scientific Review.
Felicia Hill-Briggs, Nancy E Adler, Seth A Berkowitz, Marshall H Chin, Tiffany L Gary-Webb, Ana Navas-Acien, Pamela L Thornton, Debra Haire-Joshu. Diabetes Care 2020
139
5

The prevalence of comorbid depression in adults with diabetes: a meta-analysis.
R J Anderson, K E Freedland, R E Clouse, P J Lustman. Diabetes Care 2001
5

The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
Nicole M Ehrhardt, Mary Chellappa, M Susan Walker, Stephanie J Fonda, Robert A Vigersky. J Diabetes Sci Technol 2011
83
4


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
4

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
4

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
4




IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
4


Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016.
Yiling J Cheng, Alka M Kanaya, Maria Rosario G Araneta, Sharon H Saydah, Henry S Kahn, Edward W Gregg, Wilfred Y Fujimoto, Giuseppina Imperatore. JAMA 2019
160
4


CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.
Alan J Garber, Yehuda Handelsman, George Grunberger, Daniel Einhorn, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Michael A Bush, Ralph A DeFronzo, Jeffrey R Garber,[...]. Endocr Pract 2020
198
4

Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014.
Ginger Carls, Johnny Huynh, Edward Tuttle, John Yee, Steven V Edelman. Diabetes Ther 2017
125
4


Diabetes 2030: Insights from Yesterday, Today, and Future Trends.
William R Rowley, Clement Bezold, Yasemin Arikan, Erin Byrne, Shannon Krohe. Popul Health Manag 2017
262
3

Epidemiology of diabetes and diabetes-related complications.
Anjali D Deshpande, Marcie Harris-Hayes, Mario Schootman. Phys Ther 2008
568
3


Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003-2014.
Elizabeth B Kirkland, Marc Heincelman, Kinfe G Bishu, Samuel O Schumann, Andrew Schreiner, R Neal Axon, Patrick D Mauldin, William P Moran. J Am Heart Assoc 2018
95
3


The Cost of Diabetes Care-An Elephant in the Room.
Matthew C Riddle, William H Herman. Diabetes Care 2018
73
4


The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
William H Herman, Thomas J Hoerger, Michael Brandle, Katherine Hicks, Stephen Sorensen, Ping Zhang, Richard F Hamman, Ronald T Ackermann, Michael M Engelgau, Robert E Ratner. Ann Intern Med 2005
458
3

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Rena R Wing, Paula Bolin, Frederick L Brancati, George A Bray, Jeanne M Clark, Mace Coday, Richard S Crow, Jeffrey M Curtis, Caitlin M Egan, Mark A Espeland,[...]. N Engl J Med 2013
3


Trends in Incidence of Type 1 and Type 2 Diabetes Among Youths - Selected Counties and Indian Reservations, United States, 2002-2015.
Jasmin Divers, Elizabeth J Mayer-Davis, Jean M Lawrence, Scott Isom, Dana Dabelea, Lawrence Dolan, Giuseppina Imperatore, Santica Marcovina, David J Pettitt, Catherine Pihoker,[...]. MMWR Morb Mortal Wkly Rep 2020
82
3

A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.
Elizabeth K Ely, Stephanie M Gruss, Elizabeth T Luman, Edward W Gregg, Mohammed K Ali, Kunthea Nhim, Deborah B Rolka, Ann L Albright. Diabetes Care 2017
165
3

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
3

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
3



Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
502
3

Diabetic Foot Ulcers and Their Recurrence.
David G Armstrong, Andrew J M Boulton, Sicco A Bus. N Engl J Med 2017
941
3

Prediabetes: a high-risk state for diabetes development.
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
3

2017 National Standards for Diabetes Self-Management Education and Support.
Joni Beck, Deborah A Greenwood, Lori Blanton, Sandra T Bollinger, Marcene K Butcher, Jo Ellen Condon, Marjorie Cypress, Priscilla Faulkner, Amy Hess Fischl, Theresa Francis,[...]. Diabetes Care 2017
139
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.